BiotechTube
Home/Kiora Pharmaceuticals/Eric J. Daniels, MD, MBA
EJ

Eric J. Daniels, MD, MBA

Chief Development Officer

Kiora Pharmaceuticals

Therapeutic Areas

OphthalmologyRetinal Diseases

Kiora Pharmaceuticals Pipeline

DrugIndicationPhase
KIO-301Retinitis Pigmentosa (Mutation Agnostic)Phase 1b
KIO-104Retinal InflammationPhase 2

Leadership Team at Kiora Pharmaceuticals

BM
Brian M. Strem, PhD
President & Chief Executive Officer
MT
Melissa Tosca, CPA
Chief Financial Officer
SS
Stefan Sperl, PhD
Executive Vice President of CMC and Operations
View full Kiora Pharmaceuticals profile